|
|
|||||||||
|
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail. Erratum: Vol. 49, No. RR-13In the MMWR Recommendations and Reports, "Use of Diphtheria Toxoid-Tetanus Toxoid-Acellular Pertussis Vaccine as a Five-Dose Series: Supplemental Recommendations of the Advisory Committee on Immunization Practices (ACIP)," the table on page 2 is incorrect regarding the pertussis antigens contained in ACEL-IMUNE.® ACEL-IMUNE contains inactivated pertussis toxin, 3.2 µg; filamentous hemagglutinin, 34 µg; pertactin, 1.6 µg; and type 2 fimbriae, 0.8 µg. All amounts are approximate. Disclaimer All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices. **Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.Page converted: 11/30/2000 |
|||||||||
This page last reviewed 5/2/01
|